China Tech Digest: Biotech Firms Rush To List In China, Huawei Debuts Low Price Lidar
Total0 Biopharmaceutical companies rush for IPO on Science and Technology Innovation Board Recently, numerous biopharmaceutical companies such as Nanmo Biology, Jiachuang Biology, Maiwei Biology, Dana Biology, Sailun Biology have applied for IPO on the Sci-tech Innovation Board. The companies are involved in innovative drug development, innovative drug services, original and unique drugs, and in vitro diagnostics Products and many other sub-industries. According to Wind data, as of December 21, 109 biomedical companies have attempted to list on the Sci-tech Innovation Board, accounting for 2...
Source: chinamoneynetwork.com